Institutional investors purchased a net $6.9 million shares of ORTX during the quarter ended December 2018 and now own 52.56% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FEDERATED GLOBAL INVESTMENT MANA... Bought 3.3 Million shares of Orchard Therapeutics PLC